Detecting Early Myocardial Infiltration w/Amyloid & Light Chain Deposition Disease in Multiple Myeloma Subjects
- Status
- TERMINATED
- Phase
- N/A
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Health-Related Quality of Life (QOL), Physical and Respiratory Function in Patients With Myeloma Affecting the Spine
- Status
- COMPLETED
- Phase
- N/A
Bortezomib (Velcade) - Regulatory Post Marketing Surveillance (PMS)
- Status
- COMPLETED
- Phase
- N/A
Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients
- Status
- TERMINATED
- Phase
- PHASE3
Safety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of Activity, Safety and Pharmacology of IPH2101 a Human Monoclonal Antibody in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
UARK 2009-32 Compassionate Use Study of Carfilzomib
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Autologous Bone Marrow Transplantation (BMT) Compared With Allogeneic BMT in Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide and Planning to Undergo Autologous Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States
- Status
- COMPLETED
- Phase
- PHASE2
Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
IMGN901 in Combination With Lenalidomide and Dexamethasone
- Status
- COMPLETED
- Phase
- PHASE1
Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of JNJ-26866138 (Bortezomib) in Untreated Multiple Myeloma Patients Who Are Not Candidates for Hematopoietic Stem Cell Transplant (HSCT)
- Status
- COMPLETED
- Phase
- PHASE1